A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

UniQure NV's stock plummeted over 54% after the FDA deemed the clinical data for its Huntington's disease gene therapy AMT-130 inadequate. Investors are left questioning the future of the therapy and ...

Now, it’s worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...

A record 1,434 individuals, each with a net worth of more than US$700 million, have made it onto Hurun's list of China's richest people ...

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

Dyne Therapeutics (NASDAQ: DYN) had a Monday neither it nor its investors will ever forget. This wasn't of its own making, ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Puerto Rico’s growing life science and STEM startup sector took center stage in New York City as 13 founders from the island participated in the New York-Puerto Rico Life Science Exchange, an ...

A new quarter means a new set of high-conviction stock picks from analysts at Deutsche Bank. The bank put out its fourth-quarter “fresh money” list of top investment ideas on Wednesday, making the ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nautilus Biotechnology, Inc. before investing. In this article, we go over a few ...